BioMall
Brand Store/BDB Bioscience/BD HorizonTM BB700 Mouse Anti-Human TIGIT
B
GENERAL CATALOGUE

BD HorizonTM BB700 Mouse Anti-Human TIGIT

570313 · 25 Tests

BDB Bioscience · Cat: 570313

₹140 – ₹210 approx.This price excludes freight and taxes. Please RFQ to get the final price.

Reach 3+ verified distributors

Catalog No: 570313
Category: reagents
Pack Size: 25 Tests
Brand: BDB Bioscience

Description

Multicolor flow cytometric analysis of TIGIT expression on Human peripheral blood leukocytes. Human whole blood was stained with PE Mouse Anti-Human CD56 NCAM-1 Cat. No. 555516; Middle Plots , BD Horizon BV421 Mouse Anti-Human CD4 Cat. No. 562424 , and APC Mouse Anti-Human CD45RO Cat. No. 559865; Right Plots antibodies, and with either BD Horizon BB700 Mouse IgG1, kappa Isotype Control Cat. No. 566404; Top Plots or BD Horizon BB700 Mouse Anti-Human TIGIT antibody Cat. No. 570307/570313; Bottom Plots as indicated. Erythrocytes were lysed with BD Pharm Lyse Lysing Buffer Cat. No. 555899 . Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo Software. Left Plots - The pseudocolor density plot showing the correlated expression of TIGIT or Ig Isotype control staining versus side-light scatter SSC-A signals was derived from gated events with the forward and side-light scatter characteristics of viable leukocyte populations. Middle Plots - The pseudocolor density plot showing the correlated expression of TIGIT or Ig Isotype control staining versus CD56 NCAM-1 was derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Right Plots - The pseudocolor density plot showing the correlated expression of TIGIT or Ig Isotype control staining versus CD45RO was derived from CD4-positive gated events with the forward and side light-scatter characteristics of viable lymphocytes. Multicolor flow cytometric analysis of TIGIT expression on Human peripheral blood leukocytes. Human whole blood was stained with PE Mouse Anti-Human CD56 NCAM-1 Cat. No. 555516; Middle Plots , BD Horizon BV421 Mouse Anti-Human CD4 Cat. No. 562424 , and APC Mouse Anti-Human CD45RO Cat. No. 559865; Right Plots antibodies, and with either BD Horizon BB700 Mouse IgG1, kappa Isotype Control Cat. No. 566404; Top Plots or BD Horizon BB700 Mouse Anti-Human TIGIT antibody Cat. No. 570307/570313; Bottom Plots as indicated. Erythrocytes were lysed with BD Pharm Lyse Lysing Buffer Cat. No. 555899 . Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo Software. Left Plots - The pseudocolor density plot showing the correlated expression of TIGIT or Ig Isotype control staining versus side-light scatter SSC-A signals was derived from gated events with the forward and side-light scatter characteristics of viable leukocyte populations. Middle Plots - The pseudocolor density plot showing the correlated expression of TIGIT or Ig Isotype control staining versus CD56 NCAM-1 was derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Right Plots - The pseudocolor density plot showing the correlated expression of TIGIT or Ig Isotype control staining versus CD45RO was derived from CD4-positive gated events with the forward and side light-scatter characteristics of viable lymphocytes. Show More Multicolor flow cytometric analysis of TIGIT expression on Human peripheral blood leukocytes. Human whole blood was stained with PE Mouse Anti-Human CD56 NCAM-1 Cat. No. 555516; Middle Plots , BD Horizon BV421 Mouse Anti-Human CD4 Cat. No. 562424 , and APC Mouse Anti-Human CD45RO Cat. No. 559865; Right Plots antibodies, and with either BD Horizon BB700 Mouse IgG1, kappa Isotype Control Cat. No. 566404; Top Plots or BD Horizon BB700 Mouse Anti-Human TIGIT antibody Cat. No. 570307/570313; Bottom Plots as indicated. Erythrocytes were lysed with BD Pharm Lyse Lysing Buffer Cat. No. 555899 . Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo Software. Left Plots - The pseudocolor density plot showing the correlated expression of TIGIT or Ig Isotype control staining versus side-light scatter SSC-A signals was derived from gated events with the forward and side-light scatter characteristics of viable leukocyte populations. Middle Plots - The pseudocolor density plot showing the correlated expression of TIGIT or Ig Isotype control staining versus CD56 NCAM-1 was derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Right Plots - The pseudocolor density plot showing the correlated expression of TIGIT or Ig Isotype control staining versus CD45RO was derived from CD4-positive gated events with the forward and side light-scatter characteristics of viable lymphocytes.

More from BDB Bioscience

B
BD HorizonTM BV421 Mouse Anti-Human TIGIT
570445
reagents
B
BD OptiBuildTM BV750 Mouse Anti-Human HLA-DQ
746968
reagents
B
BD OptiBuildTM BV750 Rat Anti-Mouse CD93 (Early B Lineage)
746849
reagents
B
BD OptiBuildTM BV510 Rat Anti-Mouse Delta-Like Protein 1
744997
reagents
B
BD OptiBuildTM BUV805 Mouse Anti-Human CD275
748933
reagents
B
BD OptiBuildTM BV650 Rat Anti-Mouse CD23
740456
reagents
B
BD OptiBuildTM R718 Rat Anti-Mouse CCRL2
752021
reagents
B
BD PharmingenTM Mouse B Lymphocyte Activation Antibody Cocktail, with Isotype Control; PE-CyTM7 CD25, PE CD69, & FITC CD19
558064
reagents